Corcept Therapeutics valuation

CORT · NASDAQ · USD

Compare Corcept Therapeutics
$70.07Change from previous close: +1.23%Absolute change: +$0.85

Close · November 17, 2026

Valuation

The P/E ratio is 190.2. The average price target of 5 analysts is $141.00.

Data as of November 16, 2026

Corcept Therapeutics compared with similar companies

Corcept Therapeutics's P/E (trailing 12 months): 190.2, +175% against the median of a group of 6 similar companies (69.1).

Corcept Therapeutics's metrics compared with similar companies
MetricCorcept TherapeuticsMedian25th–75th percentileBand
P/E (trailing 12 months)190.269.145.4 – 128.0High
Forward P/E16.515.79.12 – 24.0Middle
EV/EBITDA64.816.112.5 – 30.5High
Price/book18.115.75.28 – 18.1Middle
Price/sales15.48.416.66 – 15.9Middle
Gross margin98.3%91.0%59.7% – 95.3%High
Operating margin0.8%0.8%-19.7% – 24.5%Middle
Net margin6.6%0.0%-5.7% – 10.3%Middle
ROE8.2%8.2%-9.7% – 38.5%Middle
Debt/equity0.010.120.02 – 0.62Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Corcept Therapeutics: valuation over time

On the latest fiscal year's earnings (2025), Corcept Therapeutics's P/E today is 86.7, above the median of its last 10 fiscal years (27.1; between 15.7 and 103.7 from 2016 to 2025). Relative to earnings, the stock costs more than it used to.

Corcept Therapeutics P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/E
2025$34.80$0.8242.4
2024$50.39$1.2341.0
2023$32.48$0.9434.6
2022$20.31$0.8723.3
2021$19.80$0.8922.2
2020$26.16$0.8530.8
2019$12.10$0.7715.7
2018$13.36$0.6022.3
2017$18.06$1.0417.4
2016$7.26$0.07103.7

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$9.36B
Enterprise value
$7.33B
EV/revenue
7.61

Profitability and growth

ROA
0.5%
ROIC
0.6%
Revenue growth (year over year)
31.7%
Earnings growth (year over year)
24.1%

Financial health

Total debt
$8.99M
Current ratio
2.86
Quick ratio
2.50
Altman Z-Score
25.6
Piotroski F-Score
6.00

Analysts and estimates

Average price target
$141.00
High price target
$165.00
Low price target
$50.00
Analysts with a price target
5
Consensus
Buy

Shares and trading

Beta
0.46
Average volume
1.23M
Shares outstanding
109.44M
Float
97.82M
Institutional ownership
76.8%
Insider ownership
10.5%
Short interest (% of float)
9.3%
Short ratio (days)
9.81